Bone Biologics Corporation (BBLG)

NASDAQ: BBLG · IEX Real-Time Price · USD

1.110

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

1.130

+0.020 (1.80%)

Pre-market: Jul 22, 2024, 9:01 AM EDT

Bone Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Market Capitalization	1	2	3	36	-	-	Upgrade
Market Cap Growth	-73.65%	-44.81%	-91.15%	-	-	-	Upgrade
Enterprise Value	-2	-1	-4	30	12	11	Upgrade
PE Ratio	-	-0.20	-2.16	-22.51	-	-	Upgrade
PB Ratio	0.33	0.61	0.54	5.51	-	-	Upgrade
P/FCF Ratio	-0.12	-0.19	-0.90	-29.51	-	-	Upgrade
P/OCF Ratio	-0.12	-0.19	-0.90	-29.51	-	-	Upgrade
EV/EBITDA Ratio	0.34	0.14	2.92	-36.71	-14.21	-4.62	Upgrade
EV/EBIT Ratio	0.34	0.14	2.92	-36.71	-14.21	-4.62	Upgrade
EV/FCF Ratio	0.22	0.13	1.21	-24.07	-27.46	-3.47	Upgrade
Debt / Equity Ratio	-	-	-	-	-0.86	-0.95	Upgrade
Debt / EBITDA Ratio	-	-	-	-	-14.21	-4.63	Upgrade
Debt / FCF Ratio	-	-	-	-	-27.46	-3.48	Upgrade
Quick Ratio	19.61	3.64	2.96	66.81	0	0.04	Upgrade
Current Ratio	23.32	4.50	3.33	66.81	0	0.05	Upgrade
Interest Coverage	-	-	-	-1.00	-0.83	-2.51	Upgrade
Return on Equity (ROE)	-152.00%	-236.00%	-27.00%	17.30%	14.00%	31.10%	Upgrade
Return on Assets (ROA)	-121.00%	-154.80%	-23.30%	-94.70%	-67220.10%	-1006.80%	Upgrade
Return on Capital (ROIC)	-195.49%	-324.40%	-61.63%	-16.78%	41.89%	446.92%	Upgrade
Earnings Yield	-499.76%	-505.31%	-46.27%	-4.44%	-	-	Upgrade
FCF Yield	-778.47%	-539.60%	-111.16%	-3.39%	-	-	Upgrade
Buyback Yield / Dilution	-883.36%	-452.14%	-151.84%	-56.01%	0.17%	-45.07%	Upgrade
Total Shareholder Return	-883.36%	-452.14%	-151.84%	-56.01%	0.17%	-45.07%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).